Evidence map›Paper›PMID 42255259›Full record

ArticleBlood neoplasia2026

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden.

Colin J Thomas, Caroline S Myers, Jina Chung, Daniel Landsburg, Sunita D Nasta, Jakub Svoboda, Elise A Chong, Stephen J Schuster, Jordan Carter, Michael Cook and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood neoplasia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Colin J ThomasLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Caroline S MyersDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA.
Jina ChungDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA.
Daniel LandsburgLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Sunita D NastaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Jakub SvobodaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Elise A ChongLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Stephen J SchusterLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Jordan CarterLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Michael CookLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Emily TomasuloLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Omar ElghawyDepartment of Medicine, University of Pennsylvania, Philadelphia, PA.
Michael LaRiviereDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Harper HubbelingDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
John P PlastarasDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.
Alain H RookDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA.
Jennifer Villasenor-ParkDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA.
Marco RuellaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Ellen KimDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA.
Stefan K BartaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

Funding

MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCERR37CA262362 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Marco Ruella · 2022 to 2026
$2.6M
NCI NIH HHS R37 CA262362
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42255259
PMCPMC13240749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.